Article
A dominant activating mutation in the effector region of RAS abolishes IRA2 sensitivity.
Molecular and cellular biology - 1 Feb 1992
Tanaka K, Wood D R, Lin B K, Khalil M, Tamanoi F, Cannon J F
Abstract excerpt
Previously described mutations in RAS genes that cause a dominant activated phenotype affect the intrinsic biochemical properties of RAS proteins, either decreasing the intrinsic GTPase or reducing the affinity for guanine nucleotides. In this report, we describe a novel activating mutation in the RAS2 gene of Saccharomyces cerevisiae that does not alter intrinsic biochemical properties of the mutant RAS2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.